<DOC>
	<DOCNO>NCT01463098</DOCNO>
	<brief_summary>Part A : The purpose study evaluate safety tolerability single oral dos E2006 administer morning healthy male female subject . Part B : The purpose study evaluate select pharmacodynamic ( PD ) parameter ( e.g. , polysomnographically defined sleep measure ) regard dose response subject primary insomnia follow single oral dose E2006 even approximately 30 minute prior sleep period , compare 10 mg zolpidem placebo .</brief_summary>
	<brief_title>A 2-Part Single Dose Study Assess Safety , Tolerability , Pharmacokinetics , Pharmacodynamics E2006</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Zolpidem</mesh_term>
	<criteria>Key Healthy Subjects : With habitual time bed &gt; 7 hour , light 2200 2400 light 0600 0800 Who report typical sleep latency &lt; /= 30 minute With typical total sleep time ( TST ) &gt; /= 420 minute Primary Insomnia Subjects : Otherwise healthy adult male female subject diagnosis primary insomnia ( define Diagnostic Statistical Manual Mental DisordersIVText Revision [ DSMIVTR ] ) present time Screening least 3 month With score &gt; 15 Insomnia Severity Index ( ISI ) Screening Who report take &gt; /= 30 minute fall asleep least 3 night per week past month Who report 6.5 hour sleep less least 3 night per week past month With mean latency persistent sleep ( LPS ) baseline night &gt; /= 20 minute neither night &lt; 15 minute With mean wake sleep onset ( WASO ) &gt; /= 20 minute baseline night , neither night &lt; 15 minute mean TST &gt; 420 minute Key With current history sleep disorder ( e.g. , obstructive sleep apnea , restless leg syndrome [ RLS ] , narcolepsy , circadian rhythm disorder ) primary insomnia ( Part B ) Subjects clinically abnormal symptom organ impairment find medical history , symptoms/signs , vital sign , ECG finding , laboratory test result require medical treatment All female must nonchildbearing potential With known history significant neurological serious psychiatric illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>